04/15/2026
Meet the Mercer VIP Case Competition Team ✨
This year’s project focused on developing a comprehensive drug development strategy for a novel anti-TL1A therapy for moderate-to-severe ulcerative colitis.
From IND strategy and clinical trial design to regulatory planning, medical affairs, commercialization, and patient advocacy, the team built a full bench-to-bedside development plan highlighting the value of industry pharmacists.